These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12099927)

  • 1. Nitric oxide metabolites and interleukin-6 in cerebrospinal fluid from multiple sclerosis patients.
    Miljkovic Dj; Drulovic J; Trajkovic V; Mesaros S; Dujmovic I; Maksimovic D; Samardzic T; Stojsavljevic N; Levic Z; Mostarica Stojkovic M
    Eur J Neurol; 2002 Jul; 9(4):413-8. PubMed ID: 12099927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity.
    Drulović J; Dujmović I; Mesaros S; Samardzić T; Maksimović D; Stojsavljević N; Lević Z; Mostarica Stojokvić M
    Mult Scler; 2001 Feb; 7(1):19-22. PubMed ID: 11321188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course.
    Svenningsson A; Petersson AS; Andersen O; Hansson GK
    Neurology; 1999 Nov; 53(8):1880-2. PubMed ID: 10563648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker.
    Brundin L; Morcos E; Olsson T; Wiklund NP; Andersson M
    Eur J Neurol; 1999 Sep; 6(5):585-90. PubMed ID: 10457392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.
    Calabrese V; Scapagnini G; Ravagna A; Bella R; Foresti R; Bates TE; Giuffrida Stella AM; Pennisi G
    J Neurosci Res; 2002 Nov; 70(4):580-7. PubMed ID: 12404512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide as an activity marker in multiple sclerosis.
    Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
    J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.
    Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G
    Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients.
    Yuceyar N; Taşkiran D; Sağduyu A
    Clin Neurol Neurosurg; 2001 Dec; 103(4):206-11. PubMed ID: 11714562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome.
    Ikeda M; Sato I; Matsunaga T; Takahashi M; Yuasa T; Murota S
    Intern Med; 1995 Aug; 34(8):734-7. PubMed ID: 8563111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
    Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis.
    Danilov AI; Andersson M; Bavand N; Wiklund NP; Olsson T; Brundin L
    J Neuroimmunol; 2003 Mar; 136(1-2):112-8. PubMed ID: 12620649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy.
    Peltola J; Ukkonen M; Moilanen E; Elovaara I
    Neurology; 2001 Sep; 57(5):895-6. PubMed ID: 11552025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide metabolites in the cisternal cerebral spinal fluid of patients with subarachnoid hemorrhage.
    Suzuki Y; Osuka K; Noda A; Tanazawa T; Takayasu M; Shibuya M; Yoshida J
    Neurosurgery; 1997 Oct; 41(4):807-11; discussion 811-2. PubMed ID: 9316041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid nitrate levels in patients with multiple sclerosis.
    de Bustos F; Navarro JA; de Andrés C; Molina JA; Jiménez-Jiménez FJ; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Martínez-Salio A; Arenas J
    Eur Neurol; 1999 Jan; 41(1):44-7. PubMed ID: 9885328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis.
    Giovannoni G
    Mult Scler; 1998 Feb; 4(1):27-30. PubMed ID: 9532589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid nitric oxide level changes in preeclampsia.
    Celik O; Hascalik S; Turkoz Y; Hascalik M; Gokdeniz R
    Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):141-5. PubMed ID: 14597241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.
    Shukla R; Rajani M; Srivastava N; Barthwal MK; Dikshit M
    Int J Neurosci; 2006 Dec; 116(12):1391-402. PubMed ID: 17145675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cerebrospinal fluid nitrite and nitrate levels in patients with lumbar spondylosis.
    Asahara H; Yokoi I; Tamada T; Kabuto H; Ogawab N; Mori A; Inoue H
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):77-83. PubMed ID: 8824933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxynitrite formation within the central nervous system in active multiple sclerosis.
    Cross AH; Manning PT; Keeling RM; Schmidt RE; Misko TP
    J Neuroimmunol; 1998 Aug; 88(1-2):45-56. PubMed ID: 9688323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in nitrite and nitrate (NO2-/NO3-) levels in cerebrospinal fluid of patients with multiple sclerosis.
    Yamashita T; Ando Y; Obayashi K; Uchino M; Ando M
    J Neurol Sci; 1997 Dec; 153(1):32-4. PubMed ID: 9455975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.